The Tatas will continue its association with Advinus Therapeutics, the drug discovery start-up company based in Bangalore, and is committed to further invest in the company, said R Gopalakrishnan, chairman of Advinus and executive director, Tata Sons
The Tata group has earmarked about Rs 1,000 crore (Rs 10 billion) for investment over the next four years in Advinus Therapeutics, a joint venture floated by it and ex-Ranbaxy research head Rashmi Barbhaiya.
